Ultragenyx Pharmaceutical Inc. logo

Ultragenyx Pharmaceutical Inc. (RARE)

Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
22. 41
+0.63
+2.89%
$
2.15B Market Cap
- P/E Ratio
- Div Yield
1,771,421 Volume
-8.23 Eps
$ 21.78
Previous Close
Add Transaction
Day Range
21.8 22.61
Year Range
18.29 42.37
Want to track RARE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Ultragenyx Pharmaceutical Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
JCB
John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH
15,478 $588,001.18 $347,016.76 -$240,984.42 -40.98%
NR
Nicole Reese WPG Advisers LLC
11 $462.75 $246.62 -$216.13 -46.71%
BCM
Boreal Capital Management LLC Boreal Capital Management LLC
100 $3,636 $2,242 -$1,394 -38.34%